Article | Open

Proteomic Analysis of Non-depleted Serum Proteins from Bottlenose Dolphins Uncovers a High Vanin-1 Phenotype

  • Scientific Reports 6, Article number: 33879 (2016)
  • doi:10.1038/srep33879
  • Download Citation
Received:
Accepted:
Published online:

Abstract

Targeted approaches have been widely used to help explain physiological adaptations, but few studies have used non-targeted omics approaches to explore differences between diving marine mammals and terrestrial mammals. A rank comparison of undepleted serum proteins from common bottlenose dolphins (Tursiops truncatus) and pooled normal human serum led to the discovery of 11 proteins that appeared exclusive to dolphin serum. Compared to the comprehensive human plasma proteome, 5 of 11 serum proteins had a differential rank greater than 200. One of these proteins, Vanin-1, was quantified using parallel reaction monitoring in dolphins under human care and free-ranging dolphins. Dolphin serum Vanin-1 ranged between 31–106 μg/ml, which is 20–1000 times higher than concentrations reported for healthy humans. Serum Vanin-1 was also higher in dolphins under human care compared to free-ranging dolphins (64 ± 16 vs. 47 ± 12 μg/ml P < 0.05). Vanin-1 levels positively correlated with liver enzymes AST and ALT, and negatively correlated with white blood cell counts and fibrinogen in free-ranging dolphins. Major differences exist in the circulating blood proteome of the bottlenose dolphin compared to terrestrial mammals and exploration of these differences in bottlenose dolphins and other marine mammals may identify veiled protective strategies to counter physiological stress.

Introduction

In mammals, evolutionary adaptations have permitted different strategies for survival thereby allowing species to exploit a diverse array of environments. Many of these strategies are considered detrimental within the confines of normal human physiology and are consistent with the promotion of significant organ injury1. Marine mammals are similar in this regard in that some have evolved physiological and morphological adaptations that permit rigorous dives, repeated bouts of hypoxia, little access to free-water, and long periods of fasting2,3,4,5. Comparative studies demonstrated that diving leads to greater reactive oxygen species burden6, likely due to repeated peripheral vasoconstriction and organ reperfusion7,8,9,10. In response, there is a far greater need to oppose oxidative stress and this response is reflected in the elevation of antioxidant enzyme activity in tissues11,12,13 (e.g. glutathione disulfide reductase, superoxide dismutase, glutathione peroxidase), and red blood cells6 (e.g. glutathione reductase, glutathione peroxidase, superoxide dismutase and catalase). Biochemical adaptations to hypoxia include high muscle myoglobin content14, expression of cytoprotective neural globins3, an elevation in numbers of circulating red blood cells, and high per unit mass hemoglobin concentration14. Furthermore, bottlenose dolphins and killer whales (Orcinus orca) have low levels of circulating clotting factors VII and X, and a complete lack of Hageman factor (XII) which may help to prevent thrombus formation during episodes of peripheral vasoconstriction15.

In marine mammals, the high glucose demands of red blood cells and tissues can require elevated glucose production or cycling during long periods of fasting in some species16. Fasted bottlenose dolphins exhibit higher serum glucose concentrations compared to horses and cows17 and slightly higher plasma glucose levels than fed dolphins18 suggestive of a natural “diabetic-like” state that may be beneficial during times of short-term fasting. Long-term fasting hyperglycemia and insulin resistance is a hallmark of fasting Northern elephant seals19 and evidence of insulin-independent glucose uptake20,21 suggests that hormonal regulation of glucose metabolism has deviated significantly from terrestrial mammals.

Many insightful studies of marine mammal physiology and health have focused on oxygen transport, antioxidant, metabolic, and clinical laboratory-relevant proteins in the blood; however, comparative studies describing the circulating serum proteome in marine mammals have not been extensively interrogated for novel serum phenotypes that could underlie significant alternative mechanisms of protection and/or metabolic regulation. To extend the discovery of phenotypic determinants in the serum that may promote the ability of marine mammals to counter stress, we created a normalized spectral abundance factor rank-list of high abundance serum proteins from bottlenose dolphins (Tursiops truncatus)22 alongside undepleted human and pig serum proteomes generated in-house. Outlier ranked proteins were listed and one of the outlier proteins, Vanin-1, was chosen to validate the rank differences. Measurements of Vanin-1 levels in both dolphins under human-care and free-ranging dolphins were made and correlated with clinical blood laboratory values.

Results

Serum rank comparisons: dolphin vs. human and pig

Analysis of tryptic protein digests identified 58 proteins in dolphin serum, 92 proteins in human serum, and 77 proteins in pig serum (Supplemental Table 1). Albumin was the highest ranked protein in each group. We utilized terms to describe the proteins as high, medium, or low based on previous descriptions of blood proteins23,24, where high abundance protein relates to a protein concentration between 50,000–1 mg/L; medium abundance protein relates to a protein concentration between 1–0.5 mg/L, and low abundance protein relates to a protein concentration less than 0.5 mg/L. Proteins were classified based on estimated human plasma protein concentration25. The use of the term, high abundance, to describe serum proteins in dolphins is based on the fact that these proteins were identified from tryptic peptides from sera that were not depleted of major proteins. Further, tryptic peptides were not fractionated by orthogonal methods and proteins were identified from a single LC/MS/MS run with data dependent acquisition.

There were 11 dolphin serum proteins that did not match any protein on the list of 92 high abundance human serum proteins (Fig. 1). The 11 unmatched ranked dolphin protein identifications are provided in Table 1. For dolphin proteins that did not match human serum proteins, a second comparison was made with pig serum proteins to determine whether phylogenetic differences in serum proteins could simply explain the differences between dolphin and human. Three out of 11 proteins that were considered unique to the dolphin high abundance serum proteome were ranked within the high abundance pig serum proteome. Fetuin B, Extracellular matrix protein 1, and Glycosylphosphatidylinositol phospholipase D1 were all detected in undepleted pig serum. The initial 11 outlier dolphin proteins were also compared to the high confidence human plasma reference proteome25 to provide further reference with estimated abundance in a well-characterized mammalian proteome. Although Fibrinogen beta chain and gamma chain proteins were not discovered in the initial survey of human serum proteins, the dolphin Fibrinogen chains (rank: 44 ± 19 and 47 ± 17, respectively) were ranked near the top of the human reference plasma proteome (rank 18 and 21). Similar to fibrinogen chains, dolphin glutathione peroxidase 3 appears to be an outlier compared to the initial human and pig serum protein survey produced from this study; however, compared to the reference human plasma proteome, dolphin Glutathione peroxidase 3 protein is only moderately different in terms of rank (27 ± 4 in dolphin vs. 69 in human). The remaining five out of 11 dolphin serum proteins, which were not observed in the initial human and pig serum proteome analysis and had a differential rank greater than 200 compared to the reference human proteome, were: Adiponectin, Vanin-1, Polymeric immunoglobulin receptor, Adipocyte plasma membrane protein, and Deleted in malignant brain tumors 1. Of these five proteins, only adipocyte plasma membrane protein was not identified in every dolphin in at least one time point (Table 1).

Figure 1: Histogram plot of difference between in mean protein rank between dolphin serum proteins and pooled normal human serum proteins.
Figure 1

Absolute value of differences are plotted in bins of 10. Dashed box indicates 11 serum proteins that were not found in the pooled human serum proteomic dataset. Additional comparative ranking data and identifications are listed in Table 1.

Table 1: Mean ranks of eleven dolphin serum proteins not present in the undepleted pooled human serum proteome results.

Enrichment analysis

Of the 11 proteins in Table 1, seven proteins were common to high-level gene ontology biological process categories: Response to stress and Response to chemical stimuli (Supplemental Table 3). A third category, Regulation of immune system process, contained six of 11 proteins. All proteins were classified as cellular component: extracellular exosome. Evidence for cell-specific expression of human protein orthologs revealed 9 of 11 proteins are expressed in adipocytes (Supplemental Table 4). Vanin-1 and Extracellular matrix protein were not contained in the cell expression enrichment.

Serum Vanin-1 measurements

A Vanin-1 assay was developed with a calculated limit of detection of 2.5 μg/ml and a calculated lower limit of quantification of 4.5 μg/ml. The highest intra-run variability was 2.5% RSD. Twenty dolphin samples (10 human-care and 10 free-ranging) were strictly age- and sex-matched from a previously published cohort26. Clinical laboratory data for 10 human-care dolphins (age range 4–29 years) and 10 free-ranging dolphins (age range 2–28 years) are listed in Table 2. Serum concentration of Vanin-1 in dolphins under human care ranged between 47.2–106.4 μg/ml, with a mean concentration of 64.1 ± 16.3 μg/ml. Serum concentration of Vanin-1 in free-ranging dolphins ranged between 31.0–70.5 μg/ml, with a mean concentration of 46.9 ± 11.7 μg/ml. Mean Vanin-1 concentration was significantly lower in free-ranging dolphins versus dolphins under human care (Fig. 2, T-test, P < 0.05). There was no significant difference between Vanin-1 levels in males versus females for either human-care or free-ranging dolphins (P > 0.3).

Table 2: Pearson’s product moment correlation between blood clinical data and serum Vanin-1.
Figure 2: Vanin-1 concentration in the serum of managed or free-ranging bottlenose dolphins.
Figure 2

*Indicates P < 0.05 versus managed dolphins. Bars represent mean vanin-1 serum concentration. Error bars indicate standard deviation.

Correlations between routine clinical laboratory values and serum Vanin-1 concentration were determined for human-care and free-ranging populations separately. Clinical laboratory values (Supplemental Table 2) are consistent with the previously published cohort26 where human-care dolphins had lower WBCs, and higher triglycerides, cholesterol, GGT, and uric acid compared to the free-ranging dolphins. Unlike the previously published cohort, in this sub-cohort there was no difference in ALT or total iron which likely is due to the smaller sample size. Serum Vanin-1 levels were not correlated with any laboratory value in the human-care dolphin group; however, Vanin-1 was positively correlated with liver enzymes AST (ρ = 0.64) and ALT (ρ = 0.68) and inversely correlated with WBC (ρ = −0.68) and fibrinogen (ρ = −0.70) in the free-ranging dolphin group (Table 2). There was no correlation with age (Table 2, p > 0.2).

Discussion

A considerable number of proteomic studies have focused on characterizing and comparing proteomes of body fluids from humans or model laboratory animals25,27,28,29,30, as well as determining depletion strategies to investigate lower abundance proteins31. Because protein identification by mass spectrometry is tied closely to species-specific genome availability, fewer studies have interrogated the differences in the body fluid proteomes between species32,33,34 as compared to examining proteomic differences due to experimental conditions within species. Further, peptide level variation within individuals is often not captured within reference genomes and intraspecific protein comparisons can be influenced by the diversity of the proteomic database used35. In the case of marine mammals, genomic, transcriptomic, and proteomic studies are all hindered by this limitation thereby resulting in incomplete comparative analyses that can reveal unique features underlying a unique physiology. For dolphins, incomplete or non-existent sequence data is an impediment to protein identification. In this study, immunoglobulins are under-annotated or predicted in the dolphin genome and, although they comprise a major component of the serum proteome, were unable to be included in the comparison between human and pig proteomes. In spite of incomplete biological databases, the information available can be useful for identifying extraordinary features of the proteome between species as demonstrated herein.

To advance the study of serum proteins in marine mammals, we surveyed the bottlenose dolphin serum proteome and utilized ranks to investigate potential outliers in a comparison with human undepleted proteomes. This analysis revealed 11 proteins that were identified only in the dolphin (Table 1). Although the dolphin serum proteins were not discovered in the pooled normal human sample, all of these 11 proteins have been observed in the human plasma proteome25.

Enrichment analysis36 of human orthologs relative to the 11 dolphin proteins resulted in only high-level gene ontology biological process classification and no significant network membership which suggests no known biological interaction amongst the serum proteins. Of the shared common features, all 11 proteins were classified at a lower level as members of; extracellular exosomes, which is reasonable given that most serum proteins are secreted into the blood. Human protein atlas classification of cell-type expression indicated that 9 of 11 proteins were expressed in adipocytes. Given that dolphins have a blubber layer; it is interesting to speculate that the serum protein differences relative to humans and pigs may have been influenced by this anatomical characteristic. Because Vanin-1 and Extracellular Matrix Protein 1 were not included in the human adipocyte classification, it would be premature to draw any conclusions without evidence for cell-specific expression in dolphins.

To account for differences due to phylogeny, comparisons were also made to an undepleted pig serum proteome, which is a terrestrial species that shared a more recent common ancestor with the dolphin. Of the 11 dolphin proteins identified as outliers (Fig. 1), three of these proteins; Fetuin B, Extracellular matrix protein 1, and Glycosylphosphatidylinositol phospholipase D1, were identified in undepleted pig serum and could represent proteins that are generally more abundant in taxa belonging to the order Cetartiodactyla. The inclusion of two fibrinogen chain proteins in the differentially ranked serum protein list (Table 1) is dubious and likely reflects differences in the sample preparation of serum because fibrinogen reference ranges in bottlenose dolphins are within reference ranges for other mammals37. Of the remaining six dolphin proteins that were not shared by human or pig proteome datasets, five of these proteins had high absolute rank differences (greater than 200) compared to the human plasma proteome and appear to be exclusive to the high abundance serum proteome of dolphins: Adiponectin, Vanin-1, Deleted in malignant brain tumors 1, Polymeric immunoglobulin receptor, and Adipocyte plasma membrane protein. Although Glutathione peroxidase 3 was not identified in the human or pig proteome datasets, compared to the more comprehensive human plasma proteome list, the rank difference in glutathione peroxidase 3 was not included amongst the high absolute rank difference group.

Protein rankings based on normalized spectral abundance factor provide a good estimate of relative protein abundance38, but are still susceptible to interferences such as matrix effects that can affect protein estimates. Targeted reaction monitoring assays39, such as parallel reaction monitoring, that include isotopically labelled peptide standards can greatly assist in reducing variability due to instrumentation or false-discovery artifacts of peptide assignment40 and provide a better absolute estimate of protein concentration. Parallel reaction monitoring was previously utilized to measure one of the 11 proteins, adiponectin, from Table 1. Dolphin (human-care and free-ranging) serum concentrations of adiponectin measured by reaction monitoring22,26,41 range between 2.3–47.9 μg/ml. Adiponectin concentrations, measured by reaction monitoring in humans, range between 0.02 μg/ml and 3 μg/ml42,43. These absolute differences between dolphin and human adiponectin are consistent with the rank relationship between dolphins and humans (Table 1).

To further verify differences between the lower abundance human homologs and higher abundance dolphin homologs, serum Vanin-1 was measured using parallel reaction monitoring in dolphins from two different populations. Serum from free-ranging dolphins and human-care dolphins was obtained from a previously published study26 that was conducted to characterize differences in metabolic phenotype between both populations. Serum Vanin-1 concentration in all dolphins was consistently high regardless of the population from which the animal belonged (Fig. 2) suggesting that a high Vanin-1 phenotype is a common feature of dolphins and not an artifact of management. Similar to adiponectin, Vanin-1 concentration in dolphins was also consistent with the relative ranking between dolphins and humans (Table 1). Serum concentrations in a cohort of renal transplant patients suggests Vanin-1 concentration is at least very low in both pre-operative (1.9 ng/ml) and post-operative (3.7 ng/ml) patients measured by ELISA44. Substantially higher concentrations (~20–200 ng/mg protein or ~1.7–17.7 μg/ml) were measured using an ELISA from the same manufacturer in a study of normal volunteers and patients with primary immune thrombocytopenia. Despite these highly variable estimates in normal humans, Vanin-1 levels in dolphins appear to be 20–1000 times higher than human. Because reported human serum measurements from the same ELISA manufacturer were incongruent44,45 with estimates based on proteomic analysis25, we performed a product ion scan targeting the homologous human Vanin-1 peptide utilized to measure dolphin Vanin-1 in this study. No signal for the human Vanin-1 peptide was found in normal pooled human serum (data not shown) suggesting human Vanin-1 levels are indeed low and likely to be in the range of ng/ml.

Vanin-1 is a membrane-bound GPI-anchored46,47 pantetheinase expressed widely, but primarily in liver, small intestine, and kidney in humans48. As with other GPI-anchored proteins, it is predicted that Vanin-1 can be cleaved by glycosylphosphoinositol phospholipases and released into the circulation. Interestingly, Glycosylphosphoinositol phospholipase D1 was one of the 11 proteins in Table 1 that were elevated in rank compared to human and this protein is known to cleave GPI-anchored proteins49. Because Glycosylphosphoinositol phospholipase D1 was also identified from pig serum, the elevated level of Vanin-1 in dolphin serum may have resulted due to elevated expression of Vanin-1, elevated activity of Glycosylphosphoinositol phospholipase D1, or possibly a combination of expression and activity. The gene product of Vanin-1 catalyzes the conversion of pantetheine to cysteamine and pantothenate (vitamin B5). Whereas pantothenate is recycled back to acetyl-coenzyme A, the free thiol generated in this reaction, cysteamine, has attracted much attention due to its potential oxidative and antioxidative properties50. The history of research involving Vanin-1 and cysteamine presents a very complicated biological picture with many opposing conclusions. Addition of cysteamine at low concentration to leukocytes promotes H2O2-induced DNA damage; whereas, at high concentration cysteamine prevented DNA damage51. Early studies of cysteamine were primarily focused on this product as a thiol-mediated mechanism of H2O2 generation which promoted cell toxicity52. Fueling the idea of cysteamine as an injurious thiol, Vanin-1 knock-out mice lacking measureable tissue cysteamine exhibited a protective phenotype when challenged with gamma-irradiation or paraquat53. Furthermore, popular rodent models of duodenal ulcers are created through the administration of cysteamine54,55. On the other hand, Vanin-1 confers a protective phenotype to pancreatic beta islet cells56, hepatotoxic liver injury57, and red blood cells58 while cysteamine administration has been shown to reduce renal fibrosis59, renal cystinosis60, and neurodegenerative disorders61.

Although speculative, the elevation in dolphin serum Vanin-1 may lead to an enhancement of Selenium-independent glutathione peroxidase activity. In Vanin-1 knock-out mice, Selenium independent glutathione peroxidase activity in liver, thymus and testes is reduced to about one half the level of wild type mice, and administration of cysteamine restored activity to wild-type levels62. Selenium-dependent glutathione peroxidase activities are elevated in marine mammal tissues and plasma and have been implicated as a protective mechanism to counter ischemia/reperfusion injury due to diving6,12. Interestingly, glutathione peroxidase 3 was one of the top differentially ranked proteins in Table 1, but because it is a selenium-dependent glutathione peroxidase, the link between Vanin-1 and cysteamine is not supported. Because studies of selenium-independent glutathione peroxidase activity in marine mammals is lacking, the association between glutathione peroxidase activity in marine mammals and elevated Vanin-1 in the serum remains a potentially interesting question that may explain part of the high antioxidant status in marine mammal plasma6. Alternatively, because cysteamine at high concentrations has been reported to be protective only in cells under high oxidative stress63, it is interesting to speculate that high Vanin-1 levels may have evolved in response to counter the oxidative stress due to ischemia/reperfusion due to diving.

In addition to the finding that all study dolphins have high circulating levels of Vanin-1, the finding that dolphins under human care had slightly elevated (1.3 fold) serum Vanin-1 concentration was unexpected (Fig. 1). Because serum Vanin-1 levels are prone to elevate as a result of fasting64,65, the higher Vanin-1 levels in the dolphins under human care seemed unlikely because all human care dolphin samples were drawn two hours after feeding and all dolphins had evidence of having recently fed due to the presence of stomach contents detected via ultrasound. Gut content was not determined for the free-ranging dolphins, but these dolphins are known to feed frequently throughout the day66. It remains possible that the dolphins under human care had elevated levels of Vanin-1 as a result of an overnight fast that preceded a scheduled feeding and blood draw and that Vanin-1was actively declining. Alternatively, the higher serum Vanin-1 levels in human-care dolphins may help to explain part of the reason why this population of dolphins has reportedly higher serum levels of glucose, insulin, triglycerides, and incidence of hepatic steatosis compared to the free-ranging population26,67. Overexpression of Vanin-1 leads to enhanced hepatic gluconeogenesis, elevated blood glucose, and insulin resistance in C57BL/6 mice64 Further, the knock-down of Vanin-1 in db/db mice, which have elevated Vanin-1 expression and are prone to hepatic steatosis, led to the attenuation of hepatic steatosis64. The inhibition or knock-out of Vanin-1 leads to an increase in hepatic triglyceride level in fasted rats or mice65 and improves glucose tolerance and insulin sensitivity in mice fed a high fat diet68. Recent studies, however, suggest that acute inhibition of Vanin-1 activity in Zucker Diabetic Fatty rats did not change the degree of steatosis nor did it affect insulin sensitivity or glucose production68. AlthoughVanin-1 plays a role in hepatic fatty acid oxidation, and that deviation to either side of normal may lead to steatosis, the contribution of Vanin-1 to the promotion of steatosis and insulin sensitivity in non-laboratory models is less clear.

To determine whether Vanin-1 correlates with clinical laboratory values of hepatic function, we performed a Pearson product moment correlation for both populations (Table 2). Due to the small sample size, the correlation analysis was underpowered and any associations not considered significant should be tested independently using a larger population. To detect a significant (α = 0.05) correlation of 0.4 at a power of 0.80, approximately 46 dolphins would have needed to have been included in the analysis. Therefore, only strong correlations were able to be detected and lack of correlation with clinical variables in this study should be interpreted with caution. In the free-ranging population, Vanin-1 levels were positively correlated with the liver enzymes ALT and AST, and negatively correlated with fibrinogen which is synthesized primarily in the liver. The moderate correlation with circulating liver enzyme levels suggest that serum Vanin-1 may be elevated in free-ranging dolphins with liver dysfunction; a common pathological finding in stranded dolphins69. However, no correlation between Vanin-1 and any clinical blood chemistry value was made for the human-care population from which hepatic steatosis67 is also known to be prevalent. Generalizations regarding serum Vanin-1 levels and clinical correlates of health require a much larger time-controlled study to determine whether differences in serum Vanin-1 can be of value in predicting liver health status in dolphins.

In conclusion, a simple proteomic analysis of bottlenose dolphin serum revealed a suite of circulating proteins that appear to be elevated compared to normal humans and a closer terrestrial ancestor, pig. Absolute protein measurements supported the ranking data and led to the discovery that serum Vanin-1 levels are consistently and comparatively high in dolphins. Basic proteomic comparison between other marine mammals and terrestrial mammals should help to unveil significant alternative biochemical adaptations to stress protection and metabolism in marine mammals which should be incorporated in future studies.

Methods

Serum samples

The collection of blood from bottlenose dolphins under human care was performed in accordance with guidelines and regulations set forth by the Navy Marine Mammal Program Institutional Animal Care and Use Committee (IACUC) and the Navy Bureau of Medicine (Protocol #101–2012). The collection of blood from free-ranging dolphins was performed in accordance with guidelines and regulations set forth by the Mote Marine Laboratory IACUC under National Marine Fisheries Service Scientific Research Permit No. 522–1785. The collection of pig blood was performed in accordance with guidelines set forth by the Medical University of South Carolina IACUC under protocol number 3234.

For proteomic comparisons, sera from six bottlenose dolphins (Tursiops truncatus) under human care were previously collected and information regarding these samples was previously described70. Briefly, serum samples were collected at 6 time points (0, 3, 6, 12, 18, 24 weeks) during a feeding study. Baseline samples were drawn at day zero and subsequent samples were drawn after the diet was modified to include pinfish and/or mullet. Dolphins included three females aged 12, 32, and 52 years, and three males aged 8, 35, and 42 years. Blood was drawn two hours after feeding from the peduncle using a 19 or 21 gauge needle and collected in a BD Vacutainer serum separator tube. Whole blood was allowed to clot for 30–60 minutes and centrifuged at 1,100 × g for 10 minutes prior to being transferred to a cryovial for storage at −80 °C.

Yorkshire pig (Sus scrofa) serum was collected from clotted whole blood during routine surgery. Blood was drawn from an ear vein and transferred to a 1.5 ml Eppendorf TM protein Lobind tube. Blood was allowed to clot for 30 minutes at room temperature and centrifuged for 10 minutes at 1,500 × g at 4 °C. Serum was removed from the clot and stored at −80 °C.

Pooled normal human serum was purchased from Innovative Research (Novi, MI; IPLA-SER). According to the distributor’s protocol, 500–600 mLs whole blood is collected in dry bleed bags without anticoagulant from human volunteers. Whole blood is centrifuged immediately between 1 °C and 4 °C. Plasma is extracted from red blood cells and allowed to clot for 48 hours at room temperature. Clotted plasma is centrifuged for 10 mins at 5000 × g for 20 minutes. Serum is removed off the clot and stored at −80 °C.

For Vanin-1 measurements by parallel reaction monitoring. a subset of frozen serum samples were analyzed from “managed” dolphins under human-care (N = 10) and free-ranging dolphins sampled during capture-release health assessments71 (N = 10). These samples were selected from a repository of samples described in a previously published study26. Dolphins were matched for age and sex and blood draws were within one year of each other. Dolphin serum samples under human-care were collected exactly as described for dolphin serum samples utilized for proteomic studies. Whole blood from free-ranging dolphins was drawn from a highly visible vessel running through the middle of the ventral fluke using 19 gauge, ¾ inch needles connected to BD vacutainer serum separator tubes. Whole blood was centrifuged at 1,800 × g for 10 minutes at room temperature. Serum was removed from the clot, placed into a cryovial, and stored at −80 °C.

Herein, dolphins that were under human care will be referred to as such or as human-care dolphins.

Clinical laboratory data

All clinical laboratory methods for dolphins under human care and free-ranging dolphins were previously described26.

Proteomics

Proteomic analysis of the six dolphin serum samples at six different time points was previously reported in Sobolesky et al.22. Data deposited in the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository72 with the dataset identifier (PXD003425) were utilized for creating protein rankings. Proteomic analyses of pig and human sera followed a similar procedure described herein. Five microliters serum from pig or human was aliquoted and digested with trypsin accordingly22. Peptides were extracted with solid-phase cartridges (Phenomenex, Strata-X 33 μ, 60 mg) and eluted with 40% acetonitrile in 0.1% formic acid. Samples were dried by speed-vac and resuspended in mobile phase A [98% water/2% acetonitrile/0.1% formic acid]. Peptides were trapped onto a 100 μm × 1 cm C18 (100 Å with 5-μm particles) trap column (Acclaim PepMap 100; Thermo Fisher Scientific) and separated with a 75 μm × 15 cm C18 (100 Å with 3-μm particles) analytical column (Acclaim PepMap 100; ThermoFisher Scientific). Flow rate was set to 350 nl/min and peptides were eluted using a gradient from 5% to 40% mobile phase B [5% water/95% acetonitrile/0.1% formic acid] over 60 minutes on a 2D + NanoLC system (Eksigent, Dublin, CA). Mass spectrometry data were acquired with a TripleTOF 5600 System (SCIEX, Foster City, CA) with nanospray source. Source parameters were set to the following: temperature = 150 °C, source voltage = 2500 V, GS1 = 2; Curtain gas = 15; declustering potential = 100 V; collision energy = 10 V. Data were acquired in positive ion mode using information dependent acquisition. The TOF mass range was set between 350–1250 m/z. Precursor ion scans were acquired for 200 ms. Product ion scans were acquired for 50 ms for + 2 to + 5 charged parent ions. Up to 20 product ion scans were selected per cycle and excluded for 5 seconds if previously selected. Raw peptide data (.wiff) were converted to Mascot generic file format (.mgf) using the SCIEX MS Data Converter (v. 1.3 beta, July 2012). Protein identifications were made using Mascot (v. 2.4.1, Matrix Science). Dolphin data were searched against the Ensembl (release 64) turTru1 dolphin genome assembly protein database (16,598 sequences73). Pig data were searched against the reviewed (Swiss-prot) and unreviewed (Trembl) databases (release 2015_12, 26,148 protein sequences). Human data were searched against the Swiss-prot database (Release 2015_12, 20,199 protein sequences) and Swiss-prot isoform database (Release 2015_12, 21,920 protein sequences). All database searches included the common Repository of Adventitious Proteins database (cRAP; 2012.01.01; the Global Proteome Machine). The following MASCOT parameters were selected: enzyme = trypsin; max missed cleavages = 2; carbamidomethylation (Cys) was specified as a fixed modification; oxidation (Met) and pyro-glu (N-term Q) were selected as variable modifications; precursor ion tolerance = 20 ppm; fragment ion tolerance = 0.1 Da; instrument type was set to ESI-QUAD-TOF. Mascot search results were uploaded to Scaffold 4Q + (Proteome Sciences) and normalized abundance factor calculated. False discovery rate was limited in Scaffold 4Q + to 1% for both peptides and proteins. Human and pig protein identifications required two peptides. Dolphin proteins required three identified peptides to ensure a high level of confidence in the protein identification thereby making any downstream rank comparison more conservative. Proteins that did not have an identifying name in the dolphin or pig FASTA database were manually annotated by similarity comparison using BLAST and manually annotated names reflect those relevant to human proteins.

Protein rank comparisons

Protein lists were exported to a spreadsheet and contaminant proteins and immunoglobulins were removed from all species due to the lack of immunoglobulin sequence data in the dolphin proteome FASTA database. Proteins were ranked based on normalized spectral abundance factor (NSAF)74 and ranks were compiled between orthologous dolphin and human proteins. Mean ranks were calculated for the six dolphin species at each time point (0, 3, 6, 12, 18, and 24 weeks) and reordered from highest to lowest. Arithmetic mean ranks were chosen over median ranking or geometric mean ranking in accordance with the previously reported rationale for ranking of high abundance serum proteins for humans23. The absolute value of the difference between the dolphin and human serum protein rank was calculated and plotted (Fig. 1). For dolphin proteins that were not discovered in the human serum proteome analysis, individual comparisons were made against the NSAF ranked pig serum proteome that was ranked in an identical manner as the dolphin and human protein datasets. Further, dolphin proteins were also compared against the ranked human plasma proteome25. The previously published dataset from the human plasma proteome was sorted highest to lowest based on estimated plasma concentration after immunoglobulins and keratins were removed. Complete protein lists and rankings are provided in Supplemental Table 1.

Parallel reaction monitoring

For parallel reaction monitoring, a synthetic peptide was constructed (New England Peptide, Gardner, MA) pertaining to amino acids 159–172 of dolphin Vanin-1 (ENSTTRP00000000565) with incorporation of 13C/15N lysine at the c-terminus: YQYNTDVVFDSEGK^. The peptide was selected because it did not contain methionine or cysteine, did not begin with a glutamine residue, and was not in a domain that is known to be modified in mammals according to Uniprot annotation. As such, only a single tryptic peptide met all criteria for dolphin Vanin-1. Serum samples were prepared as described for proteomic analysis and followed procedures described in ref. 22. Five μls serum was digested with trypsin (Trypsin gold, Promega) at a 1:10 ratio in 50 mM ammonium bicarbonate/0.1% anionic acid-labile surfactant (Protea Bioscences, Morgantown. WV). Prior to solid phase extraction, 6 pmols peptide standard was spiked into the digest resulting in a total of 150 fmols injected on column. All chromatography and acquisition parameters were the same as described above with the exception that product ion collision energy was set to 36. The y12+1 ion was extracted for quantification of the native peptide (832.9 −>1373.62 ± 0.1 m/z) and standard peptide (836.9 −>1381.62 ± 0.1 m/z). An external calibration curve from 0.78 fmol/μl to 150 fmol/μl was constructed by spiking the isotope labelled standard peptide in dolphin serum protein trypsin digest matrix. Quantitative measurements were calculated by area under the curve for ion pairs in MultiQuant (v 2.0.2, AB Sciex). An experimental blank was processed in triplicate to calculate the limit of detection (LOD) and limit of quantification (LOQ) for the stable isotope labeled peptide on the day of the analytical run. Regression was performed using a linear fit with 1/x weighting (y = 1729.95x + 942.35, r = 0.997). LOD was calculated as 3σ/slope of the blank and LOQ was calculated as 10σ/slope75. Assay variability was determined by injecting two samples in triplicate at the beginning, middle and end of the run and %RSD was calculated.

Statistics

Clinical and analytical data were tested by T-test if data had normal distributions or Mann-Whitney U test for non-normally distributed data. Normality was tested using the Shapiro-Wilk test and equal variance tested using the Equal Variance Test in Sigmaplot version 11.0. Significance was defined as P < 0.05. Correlations were determined using Pearson’s product moment. All data are expressed as mean ± standard deviation unless otherwise noted.

Enrichment analysis

Orthologous human protein identifiers were used in place of dolphin protein identifiers for enrichment analysis. Proteins were classified by Gene ontology (GO) using WebGestalt36 with the following criteria: Hypergeometric statistical method; Benjamini-Hochberg multiple testing; Significance level 0.05; Minimum Number of Genes per Category = 5. Cell-specific expression was categorized using the Human Protein Atlas76 database through the gene profiling tool G-Profiler77 using the following criteria: Significant only selected; Size of query = 3; Significance threshold = Benjamini-Hochberg FDR.

Data availability

Human and Pig proteomic data is available via ProteomeXchange with identifier PXD004967.

Additional Information

How to cite this article: Sobolesky, P. et al. Proteomic Analysis of Non-depleted Serum Proteins from Bottlenose Dolphins Uncovers a High Vanin-1 Phenotype. Sci. Rep. 6, 33879; doi: 10.1038/srep33879 (2016).

References

  1. 1.

    & Kidney biomimicry–a rediscovered scientific field that could provide hope to patients with kidney disease. Arch Med Res 44, 584–590 (2013).

  2. 2.

    et al. Deadly diving? Physiological and behavioural management of decompression stress in diving mammals. Proc Biol Sci 279, 1041–1050 (2012).

  3. 3.

    et al. Running, swimming and diving modifies neuroprotecting globins in the mammalian brain. Proc Biol Sci 275, 751–758 (2008).

  4. 4.

    & Blood chemistry homeostasis during prolonged fasting in the northern elephant seal. Am J Physiol 242, R591–R595 (1982).

  5. 5.

    & Effects of fresh and seawater ingestion on osmoregulation in Atlantic bottlenose dolphins (Tursiops truncatus). J Comp Physiol B 180, 563–576 (2010).

  6. 6.

    et al. Comparison between the antioxidant status of terrestrial and diving mammals. Comp Biochem Physiol A Mol Integr Physiol 133, 885–892 (2002).

  7. 7.

    , & The Regulation of Arterial Blood Pressure in the Seal During Diving. American Journal of Physiology 135, 557–566 (1942).

  8. 8.

    , , & Cessation of renal function during diving in the trained seal (Phoca vitulina). J Cell Comp Physiol 58, 261–265 (1961).

  9. 9.

    , & Adrenergic innervation of large arteries in the seal. Comp Gen Pharmacol 4, 271–276 (1973).

  10. 10.

    et al. Regional blood flow during simulated diving in the conscious Weddell seal. J Appl Physiol Respir Environ Exerc Physiol 47, 968–973 (1979).

  11. 11.

    , , & Coping with physiological oxidative stress: a review of antioxidant strategies in seals. J Comp Physiol B 182, 741–750 (2012).

  12. 12.

    , & Antioxidant enzymes in ringed seal tissues: potential protection against dive-associated ischemia/reperfusion. Comp Biochem Physiol C Toxicol Pharmacol 142, 198–204 (2006).

  13. 13.

    , & Glutathione protection against dive-associated ischemia/reperfusion in ringed seal tissues. Journal of Experimental Marine Biology and Ecology 345, 110–118 (2007).

  14. 14.

    , & Elevated carboxyhemoglobin in a marine mammal, the northern elephant seal. J Exp Biol 217, 1752–1757 (2014).

  15. 15.

    , & Hageman Factor (Factor XII) Deficiency in Marine Mammals. Science 166, 1420–1422 (1969).

  16. 16.

    , & Glucose production and substrate cycle activity in a fasting adapted animal, the northern elephant seal. J Exp Biol 208, 859–868 (2005).

  17. 17.

    et al. Comparison of Cholesterol Lipoprotein Profile and Levels of Blood Biomarker for Lipid Metabolism in Plasma of Dolphins, Horses and Cows. Journal of Animal and Veterinary Advances 11, 3781–3784 (2012).

  18. 18.

    & Big brains and blood glucose: common ground for diabetes mellitus in humans and healthy dolphins. Comp Med 57, 390–395 (2007).

  19. 19.

    , & A non-traditional model of the metabolic syndrome: the adaptive significance of insulin resistance in fasting-adapted seals. Front Endocrinol (Lausanne) 4, 164 (2013).

  20. 20.

    , , & Glut4 is upregulated despite decreased insulin signaling during prolonged fasting in northern elephant seal pups. Am J Physiol Regul Integr Comp Physiol 300, R150–R154 (2011).

  21. 21.

    , , & 5′AMP-activated protein kinase activity is increased in adipose tissue of northern elephant seal pups during prolonged fasting-induced insulin resistance. The Journal of endocrinology 209, 317–325 (2011).

  22. 22.

    , , , & Feeding a Modified Fish Diet to Bottlenose Dolphins Leads to an Increase in Serum Adiponectin and Sphingolipids. Front Endocrinol (Lausanne) 7 (2016).

  23. 23.

    , & High-abundance polypeptides of the human plasma proteome comprising the top 4 logs of polypeptide abundance. Clin Chem 54, 1608–1616 (2008).

  24. 24.

    & Protein quantitation through targeted mass spectrometry: the way out of biomarker purgatory? Clin Chem 54, 1749–1752 (2008).

  25. 25.

    et al. A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas. Mol Cell Proteomics 10, M110 006353 (2011).

  26. 26.

    et al. Blood-Based Indicators of Insulin Resistance and Metabolic Syndrome in Bottlenose Dolphins (Tursiops truncatus). Front Endocrinol (Lausanne) 4, 136 (2013).

  27. 27.

    & The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 1, 845–867 (2002).

  28. 28.

    et al. Investigation of the mouse serum proteome. J Proteome Res 4, 1561–1568 (2005).

  29. 29.

    et al. A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry. Proteomics 7, 469–473 (2007).

  30. 30.

    , , , & The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome Biol 7, R80 (2006).

  31. 31.

    et al. Multi-component immunoaffinity subtraction chromatography: an innovative step towards a comprehensive survey of the human plasma proteome. Proteomics 3, 422–432 (2003).

  32. 32.

    , & Mammalian embryonic cerebrospinal fluid proteome has greater apolipoprotein and enzyme pattern complexity than the avian proteome. J Proteome Res 4, 2420–2428 (2005).

  33. 33.

    et al. A comparative proteomic analysis of human and rat embryonic cerebrospinal fluid. J Proteome Res 6, 3537–3548 (2007).

  34. 34.

    et al. Farm animal serum proteomics and impact on human health. Int J Mol Sci 15, 15396–15411 (2014).

  35. 35.

    et al. Protein Database and Quantitative Analysis Considerations when Integrating Genetics and Proteomics to Compare Mouse Strains. J Proteome Res 10, 2905–2912 (2011).

  36. 36.

    , , & WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013. Nucleic Acids Res 41, W77–83 (2013).

  37. 37.

    & CRC handbook of marine mammal medicine, (CRC Press, Boca Raton, FL, 2001).

  38. 38.

    et al. Estimating relative abundances of proteins from shotgun proteomics data. BMC Bioinformatics 13, 308 (2012).

  39. 39.

    , , , & Parallel reaction monitoring for high resolution and high mass accuracy quantitative, targeted proteomics. Mol Cell Proteomics 11, 1475–1488 (2012).

  40. 40.

    & An assessment of false discovery rates and statistical significance in label-free quantitative proteomics with combined filters. BMC Bioinformatics 10, 43 (2009).

  41. 41.

    , , , & Ratiometric Measurements of Adiponectin by Mass Spectrometry in Bottlenose Dolphins (Tursiops truncatus) with Iron Overload Reveal an Association with Insulin Resistance and Glucagon. Front Endocrinol (Lausanne) 4, 132 (2013).

  42. 42.

    , , , & Advances in multiplexed MRM-based protein biomarker quantitation toward clinical utility. Biochimica et biophysica acta 1844, 917–926 (2014).

  43. 43.

    , & Quantification of intermediate-abundance proteins in serum by multiple reaction monitoring mass spectrometry in a single-quadrupole ion trap. Analytical Chemistry 78, 5762–5767 (2006).

  44. 44.

    , , & Serum vanin-1 levels in renal transplant patients. Exp Clin Transplant 12, 113–116 (2014).

  45. 45.

    , , & Value of vanin-1 assessment in adult patients with primary immune thrombocytopenia. Platelets 25, 86–92 (2014).

  46. 46.

    et al. Pantetheinase activity of membrane-bound Vanin-1: lack of free cysteamine in tissues of Vanin-1 deficient mice. FEBS Lett 483, 149–154 (2000).

  47. 47.

    et al. Vanin-1, a novel GPI-linked perivascular molecule involved in thymus homing. Immunity 5, 391–405 (1996).

  48. 48.

    et al. Towards a knowledge-based Human Protein Atlas. Nat Biotechnol 28, 1248–1250 (2010).

  49. 49.

    et al. Release of GPI-anchored membrane proteins by a cell-associated GPI-specific phospholipase D. The EMBO Journal 13, 1741–1751 (1994).

  50. 50.

    , , & Role of the Vnn1 pantetheinase in tissue tolerance to stress. Biochem Soc Trans 42, 1094–1100 (2014).

  51. 51.

    , & Simultaneous protective and damaging effects of cysteamine on intracellular DNA of leukocytes. Free Radic Biol Med 4, 141–145 (1988).

  52. 52.

    & Mechanisms for the cytotoxicity of cysteamine. Toxicol Sci 63, 57–64 (2001).

  53. 53.

    et al. Vanin-1−/− mice exhibit a glutathione-mediated tissue resistance to oxidative stress. Mol Cell Biol 24, 7214–7224 (2004).

  54. 54.

    et al. New mechanistic explanation for the localization of ulcers in the rat duodenum: role of iron and selective uptake of cysteamine. Arch Biochem Biophys 525, 60–70 (2012).

  55. 55.

    & Experimental model for production of perforating duodenal ulcers by cysteamine in the rat. Nature 244, 458–459 (1973).

  56. 56.

    et al. Mouse vanin-1 is cytoprotective for islet beta cells and regulates the development of type 1 diabetes. Diabetologia 51, 1192–1201 (2008).

  57. 57.

    et al. Enhanced hepatotoxicity by acetaminophen in Vanin-1 knockout mice is associated with deficient proliferative and immune responses. Biochimica et biophysica acta 1862, 662–669 (2016).

  58. 58.

    et al. Serum pantetheinase/vanin levels regulate erythrocyte homeostasis and severity of malaria. Am J Pathol 185, 3039–3052 (2015).

  59. 59.

    et al. Cysteamine modulates oxidative stress and blocks myofibroblast activity in CKD. J Am Soc Nephrol 25, 43–54 (2014).

  60. 60.

    et al. Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults. Kidney Int 81, 179–189 (2012).

  61. 61.

    & Potential of cystamine and cysteamine in the treatment of neurodegenerative diseases. Prog Neuropsychopharmacol Biol Psychiatry 35, 380–389 (2011).

  62. 62.

    et al. Cystamine restores GSTA3 levels in Vanin-1 null mice. Free Radic Biol Med 44, 1088–1096 (2008).

  63. 63.

    , , , & Effect of cysteamine on oxidative stress-induced cell death of human corneal endothelial cells. Curr Eye Res 36, 910–917 (2011).

  64. 64.

    et al. Vanin-1 is a key activator for hepatic gluconeogenesis. Diabetes 63, 2073–2085 (2014).

  65. 65.

    et al. PPAR-alpha dependent regulation of vanin-1 mediates hepatic lipid metabolism. J Hepatol 61, 366–372 (2014).

  66. 66.

    et al. Evaluation of potential protective factors against metabolic syndrome in bottlenose dolphins: feeding and activity patterns of dolphins in sarasota bay, Florida. Front Endocrinol (Lausanne) 4, 139 (2013).

  67. 67.

    , , & Leger, J. Hemochromatosis and fatty liver disease: building evidence for insulin resistance in bottlenose dolphins (Tursiops truncatus). J Zoo Wildl Med 43, S35–47 (2012).

  68. 68.

    et al. Genetic and pharmacological inhibition of vanin-1 activity in animal models of type 2 diabetes. Sci Rep 6, 21906 (2016).

  69. 69.

    et al. Adrenal Gland and Lung Lesions in Gulf of Mexico Common Bottlenose Dolphins (Tursiops truncatus) Found Dead following the Deepwater Horizon Oil Spill. PLoS One 10, e0126538 (2015).

  70. 70.

    et al. Increased Dietary Intake of Saturated Fatty Acid Heptadecanoic Acid (C17:0) Associated with Decreasing Ferritin and Alleviated Metabolic Syndrome in Dolphins. PLoS One 10, e0132117 (2015).

  71. 71.

    et al. Bottlenose Dolphins as Marine Ecosystem Sentinels: Developing a Health Monitoring System. EcoHealth 1, 246–254 (2004).

  72. 72.

    et al. The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013. Nucleic Acids Res 41, D1063–1069 (2013).

  73. 73.

    et al. A high-resolution map of human evolutionary constraint using 29 mammals. Nature 478, 476–482 (2011).

  74. 74.

    et al. Statistical analysis of membrane proteome expression changes in Saccharomyces cerevisiae. J Proteome Res 5, 2339–2347 (2006).

  75. 75.

    & Limit of Detection A Closer Look at the IUPAC Definition. Analytical Chemistry 55, 712A–724A (1983).

  76. 76.

    et al. Proteomics. Tissue-based map of the human proteome. Science 347, 1260419 (2015).

  77. 77.

    et al. g:Profiler-a web server for functional interpretation of gene lists (2016 update). Nucleic Acids Res 44, W83–89 (2016).

Download references

Acknowledgements

This study was supported in part by the Office of Naval Research Awards N000141410361/N000141612160 and ONR Award N000141210294. Samples from dolphins in Sarasota Bay, FL, USA, were collected through the efforts of the staff, volunteers, and collaborators of the Chicago Zoological Society’s Sarasota Dolphin Research Program, with additional funding from Dolphin Quest, Inc., Georgia Aquarium, and the Office of Naval Research. We wish to thank Benjamin Neely for assistance with proteomic database construction, Alison Bland for her assistance with technical aspects of this study, the Nephrology Proteomics Laboratory, and the anonymous reviewers who helped to considerably refine the manuscript.

Author information

Affiliations

  1. Division of Nephrology, Department of Medicine, Medical University of South Carolina, Charleston, SC, 29425, USA

    • Philip Sobolesky
    •  & Michael G. Janech
  2. Translational Medicine and Research Program, National Marine Mammal Foundation, San Diego, CA 92106, USA

    • Celeste Parry
    •  & Stephanie Venn-Watson
  3. Grice Marine Laboratory, Department of Biology, College of Charleston, Charleston, SC 29412, USA

    • Baylye Boxall
    •  & Michael G. Janech
  4. Chicago Zoological Society’s Sarasota Dolphin Research Program, c/o Mote Marine Laboratory, Sarasota, FL 34326, USA

    • Randall Wells

Authors

  1. Search for Philip Sobolesky in:

  2. Search for Celeste Parry in:

  3. Search for Baylye Boxall in:

  4. Search for Randall Wells in:

  5. Search for Stephanie Venn-Watson in:

  6. Search for Michael G. Janech in:

Contributions

P.S., B.B. and M.G.J. all contributed to the proteomic analysis, assay design and measurements of Vanin-1 in dolphins. C.P., S.V.-W. and R.W. contributed samples, clinical data, and analysis of clinical data. All authors participated in the writing of the manuscript and interpretation of the data.

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Michael G. Janech.

Supplementary information

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Creative Commons BYThis work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/